HK1219063A1 - 包含透明質酸的藥物組合物用於治療黑椎間盤疾病 - Google Patents

包含透明質酸的藥物組合物用於治療黑椎間盤疾病

Info

Publication number
HK1219063A1
HK1219063A1 HK16107139.9A HK16107139A HK1219063A1 HK 1219063 A1 HK1219063 A1 HK 1219063A1 HK 16107139 A HK16107139 A HK 16107139A HK 1219063 A1 HK1219063 A1 HK 1219063A1
Authority
HK
Hong Kong
Prior art keywords
treatment
pharmaceutical compositions
hyaluronic acid
compositions containing
containing hyaluronic
Prior art date
Application number
HK16107139.9A
Other languages
English (en)
Inventor
Nicola Giordan
Pierangelo Bellato
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of HK1219063A1 publication Critical patent/HK1219063A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs
HK16107139.9A 2013-04-24 2016-06-21 包含透明質酸的藥物組合物用於治療黑椎間盤疾病 HK1219063A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000110A ITPD20130110A1 (it) 2013-04-24 2013-04-24 Composizioni farmaceutiche comprendenti acido ialuronico per il trattamento del black disc
PCT/IB2014/060928 WO2014174450A1 (en) 2013-04-24 2014-04-23 Pharmaceutical compositions containing hyaluronic acid for use in the treatment of black disk disease

Publications (1)

Publication Number Publication Date
HK1219063A1 true HK1219063A1 (zh) 2017-03-24

Family

ID=48579315

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16107139.9A HK1219063A1 (zh) 2013-04-24 2016-06-21 包含透明質酸的藥物組合物用於治療黑椎間盤疾病

Country Status (16)

Country Link
US (1) US10064887B2 (zh)
EP (1) EP2988792B1 (zh)
CN (1) CN105188785B (zh)
CA (1) CA2910104C (zh)
CY (1) CY1119065T1 (zh)
DK (1) DK2988792T3 (zh)
EA (1) EA028443B1 (zh)
ES (1) ES2638659T3 (zh)
HK (1) HK1219063A1 (zh)
IT (1) ITPD20130110A1 (zh)
LT (1) LT2988792T (zh)
MX (1) MX353411B (zh)
PT (1) PT2988792T (zh)
SA (1) SA515370029B1 (zh)
SI (1) SI2988792T1 (zh)
WO (1) WO2014174450A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201616849D0 (en) * 2016-10-04 2016-11-16 Nat Univ Ireland Regneration of diseased intervertebral discs
CN111194218B (zh) * 2017-09-19 2024-02-20 香港科技大学 生物可相容材料以及用于制备和使用所述生物可相容材料的方法
IT202100032111A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Nuovi sostituti biocompatibili dell’umor vitreo

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH666897A5 (fr) 1983-10-11 1988-08-31 Fidia Spa Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques.
IT1263393B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US8357147B2 (en) * 2005-08-17 2013-01-22 Spinal Restoration, Inc. Method for repairing intervertebral discs
US20080075657A1 (en) * 2006-04-18 2008-03-27 Abrahams John M Biopolymer system for tissue sealing
CN101285052B (zh) * 2008-04-29 2010-06-30 中国人民解放军第三军医大学第二附属医院 一种应用于组织工程椎间盘髓核构建的种子细胞接种方法
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
IT1402384B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus megaterium
IT1402385B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus subtilis
CN101954123A (zh) * 2010-10-21 2011-01-26 中国人民解放军第三军医大学第二附属医院 一种人工椎间盘复合体组织及其制备方法

Also Published As

Publication number Publication date
ITPD20130110A1 (it) 2014-10-25
CY1119065T1 (el) 2018-01-10
EP2988792B1 (en) 2017-05-31
CA2910104A1 (en) 2014-10-30
LT2988792T (lt) 2017-08-25
DK2988792T3 (en) 2017-07-31
CA2910104C (en) 2021-06-08
EP2988792A1 (en) 2016-03-02
WO2014174450A1 (en) 2014-10-30
SA515370029B1 (ar) 2018-04-29
ES2638659T3 (es) 2017-10-23
PT2988792T (pt) 2017-08-30
US20160067274A1 (en) 2016-03-10
MX2015014868A (es) 2016-03-09
EA201591859A1 (ru) 2016-04-29
US10064887B2 (en) 2018-09-04
CN105188785B (zh) 2017-11-17
MX353411B (es) 2018-01-10
CN105188785A (zh) 2015-12-23
EA028443B1 (ru) 2017-11-30
SI2988792T1 (sl) 2017-09-29

Similar Documents

Publication Publication Date Title
HRP20181364T1 (hr) Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
HK1209788A1 (zh) 用於治療溶酶體貯積症的方法和組合物
IL236221A (en) History of theophyridone and pharmacological preparations containing them for the treatment of diseases
EP2847152A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF METABOLIC SYNDROME
IL233674A0 (en) Preparations and methods for using phorbol esters for stroke treatment
HK1198909A1 (zh) 用於治療肝臟疾病和障礙的組合物和方法
IL235058A0 (en) Pharmaceutical combinations for the treatment of metabolic disorders
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
PL2862565T3 (pl) Farmaceutyczna kompozycja ibuprofenu i tramadolu do zastosowania w okulistyce
EP2911683A4 (en) INCREASED COMPOSITION FOR THE TREATMENT OF DISEASES WITH ALLOGENIC AUTOPHAGOSOMES
HUE037179T2 (hu) Gyógyászati kompozíciók izom-rendellenességek kezelésére
EP3007702A4 (en) LIQUID PHARMACEUTICAL COMPOSITION WITH PIROXICAM AND HYALURONIC ACID FOR THE TREATMENT OF OSTEOARTHRITIS
PL2903608T3 (pl) Kompozycja farmaceutyczna obejmująca kwas propionowy do stosowania w leczeniu infekcji wirusowych
HK1219063A1 (zh) 包含透明質酸的藥物組合物用於治療黑椎間盤疾病
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome
HUP1200552A2 (en) Pharmaceutical compositions for the treatment of high blood pressure
SI2812351T1 (sl) Farmacevtski sestavek za zdravljenje multiple skleroze
HUP1300454A2 (hu) Daganatos betegségek gyógyítására és megelõzésére alkalmas gyógyászati készítmények, és eljárás azok elõállítására
GB201207064D0 (en) Pharmaceutical compositions comprising 15-hetre and methods of using the same